Patents by Inventor Hiroyoshi Nanba

Hiroyoshi Nanba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10494338
    Abstract: The present invention relates to a novel prostaglandin derivative having an alkynyl group on ?-chain, particularly, a novel prostaglandin derivative having a double bond at the 2-position and an alkynyl group on the ?-chain and a medicament containing the compound as an active ingredient. According to the present invention, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof; wherein each symbol is as defined in the present specification, or a cyclodextrin clathrate compound thereof, and a medicament containing the compound as an active ingredient, particularly, a medicament for the prophylaxis or treatment of a blood flow disorder associated with spinal canal stenosis or chronic arterial occlusion, can be provided.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 3, 2019
    Assignees: AGC INC., NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Arata Yasuda, Yasushi Matsumura, Kazuyoshi Sawada, Hiroyoshi Nanba, Kazuki Taguchi
  • Publication number: 20190135743
    Abstract: The present invention relates to a novel prostaglandin derivative having an alkynyl group on ?-chain, particularly, a novel prostaglandin derivative having a double bond at the 2-position and an alkynyl group on the ?-chain and a medicament containing the compound as an active ingredient. According to the present invention, a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof; wherein each symbol is as defined in the present specification, or a cyclodextrin clathrate compound thereof, and a medicament containing the compound as an active ingredient, particularly, a medicament for the prophylaxis or treatment of a blood flow disorder associated with spinal canal stenosis or chronic arterial occlusion, can be provided.
    Type: Application
    Filed: May 9, 2017
    Publication date: May 9, 2019
    Applicants: AGC INC., NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Arata YASUDA, Yasushi MATSUMURA, Kazuyoshi SAWADA, Hiroyoshi NANBA, Kazuki TAGUCHI
  • Patent number: 9540338
    Abstract: A cinnamic acid amide derivative having an excellent analgesic action is disclosed herein. The cinnamic acid amide derivative shows excellent analgesic actions to not only a nociceptive pain model animal, but also a neuropathic pain model animal, which is very useful as an agent for treating various pain diseases showing acute or chronic pains or neuropathic pains. The cinnamic acid amide derivative may be a compound represented by formula (I).
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: January 10, 2017
    Assignee: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro Ookubo, Ko Nakamura, Yoshitaka Nakazawa, Hiroyoshi Nanba, Hiroyuki Yoshida
  • Publication number: 20150322024
    Abstract: The present invention provides a cinnamic acid amide derivative having an excellent analgesic action. The cinnamic acid amide derivative of the present invention is a compound showing excellent analgesic actions to not only a nociceptive pain model animal but also a neuropathic pain model animal, which is very useful as an agent for treating various pain diseases showing acute or chronic pains or neuropathic pains.
    Type: Application
    Filed: December 27, 2013
    Publication date: November 12, 2015
    Applicant: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro OOKUBO, Ko NAKAMURA, Yoshitaka NAKAZAWA, Hiroyoshi NANBA, Hiroyuki YOSHIDA
  • Patent number: 9150510
    Abstract: The amino acid derivative of the present invention provides a novel compound that shows excellent analgesic action. The amino acid derivative of the present invention is a novel compound that shows excellent analgesic action to not only a model animal for nociceptive pains but also a model animal for neuropathic pains, so that the amino acid derivative is very useful as a drug for treating various pain diseases.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: October 6, 2015
    Assignee: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro Ookubo, Ko Nakamura, Hiroyoshi Nanba, Hiroyuki Yoshida, Yoshitaka Nakazawa
  • Patent number: 8324261
    Abstract: The present invention is to provide a novel compound which is useful as a pharmaceutical agent such as an analgesic. The present invention is to provide the novel histidine derivative having an excellent analgesic action and the like. The compound of the present invention has a very high intermigration into the blood upon oral administration and is very useful as a pharmaceutical agent, especially an analgesic for the treatment of acute or chronic pain diseases and of neuropathic pain diseases.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: December 4, 2012
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Yoshitaka Nakazawa, Kenji Mitsuda, Tomohiro Ookubo, Teppei Seguchi, Hiroyoshi Nanba
  • Publication number: 20110172442
    Abstract: The amino acid derivative of the present invention provides a novel compound that shows excellent analgesic action. The amino acid derivative of the present invention is a novel compound that shows excellent analgesic action to not only a model animal for nociceptive pains but also a model animal for neuropathic pains, so that the amino acid derivative is very useful as a drug for treating various pain diseases.
    Type: Application
    Filed: September 17, 2009
    Publication date: July 14, 2011
    Applicant: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro Ookubo, Ko Nakamura, Hiroyoshi Nanba, Hiroyuki Yoshida, Yoshitaka Nakazawa
  • Publication number: 20100152459
    Abstract: The present invention is to provide a novel compound which is useful as a pharmaceutical agent such as an analgesic. The present invention is to provide the novel histidine derivative having an excellent analgesic action and the like. The compound of the present invention has a very high intermigration into the blood upon oral administration and is very useful as a pharmaceutical agent, especially an analgesic for the treatment of acute or chronic pain diseases and of neuropathic pain diseases.
    Type: Application
    Filed: July 18, 2008
    Publication date: June 17, 2010
    Applicant: NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Yoshitaka Nakazawa, Kenji Mitsuda, Tomohiro Ookubo, Teppei Seguchi, Hiroyoshi Nanba